ACQUISITION OF CORE ONCOLOGY'S PROSTATE BRACHYTHERAPY CUSTOMER BASE (Tables)

12 Months Ended

Dec. 31, 2012

Asset Acquisition Disclosure [Abstract]

Schedule of finite-lived intangible assets acquired as part of business combination

	Amount		Estimated Life
Inventories	$	258
Developed technology equipment		181	7 years
Intangibles
Customer relationships		4,404	7 years
Non-compete agreements		373	5 years
Developed technology		107	1.5 years
		4,884	6.7 years
Total cost of assets acquired	$	5,323